Agios: Novo's Sickle Cell Win Changes The PK Activator Game (Rating Downgrade)
Summary
Agios (AGIO) downgraded to Hold as Novo Nordisk rivalry and FDA/REMS risks hit sickle cell & thalassemia; pipeline and cash burn key—read now.
Description
Agios (AGIO) downgraded to Hold as Novo Nordisk rivalry and FDA/REMS risks hit sickle cell & thalassemia; pipeline and cash burn key—read now.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source